(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are BioNTech SE, Moderna, and Tupperware Brands Corporation.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | BioNTech SE (BNTX) | 118.17 | 9.93% | 2023-05-23 13:36:36 |
| 2 | Moderna (MRNA) | 139.07 | 9.73% | 2023-05-23 13:44:29 |
| 3 | Tupperware Brands Corporation (TUP) | 0.92 | 8.83% | 2023-05-23 12:23:08 |
| 4 | Fastly (FSLY) | 14.48 | 7.6% | 2023-05-23 13:47:04 |
| 5 | Xenetic Biosciences (XBIO) | 2.99 | 7.55% | 2023-05-23 13:45:41 |
| 6 | Telephone and Data Systems (TDS) | 7.47 | 7.48% | 2023-05-23 07:15:10 |
| 7 | VerifyMe (VRME) | 1.47 | 6.52% | 2023-05-23 13:37:18 |
| 8 | Palantir (PLTR) | 12.60 | 6.46% | 2023-05-23 13:47:02 |
| 9 | Novavax (NVAX) | 8.02 | 6.43% | 2023-05-23 13:41:31 |
| 10 | Tidewater (TDW) | 47.92 | 6.37% | 2023-05-23 07:17:08 |
The three biggest losers today are Safeguard Scientifics New, Canopy Growth, and Heico Corporation.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Safeguard Scientifics New (SFE) | 1.57 | -9.77% | 2023-05-22 23:12:07 |
| 2 | Canopy Growth (CGC) | 1.06 | -9.4% | 2023-05-23 13:22:58 |
| 3 | Heico Corporation (HEI) | 164.72 | -7.95% | 2023-05-23 13:41:20 |
| 4 | 10x Genomics (TXG) | 52.83 | -7.48% | 2023-05-23 13:45:27 |
| 5 | Zoom (ZM) | 66.22 | -7.27% | 2023-05-23 13:45:53 |
| 6 | Riot Blockchain (RIOT) | 11.34 | -7.04% | 2023-05-23 13:45:00 |
| 7 | AutoZone (AZO) | 2436.14 | -7.01% | 2023-05-23 13:38:12 |
| 8 | Aurora Cannabis (ACB) | 0.62 | -6.72% | 2023-05-23 13:47:23 |
| 9 | Align Technology (ALGN) | 281.38 | -6.47% | 2023-05-23 13:37:33 |
| 10 | Las Vegas Sands Corp (LVS) | 55.76 | -6.27% | 2023-05-23 13:42:26 |
Winners today
1. BioNTech SE (BNTX) – 9.93%
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It also develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I clinical trial to treat multiple solid tumors; and BNT312, which is in Phase I clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase II clinical trial to treat ovarian cancer and Phase I clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.
NASDAQ ended the session with BioNTech SE rising 9.93% to $118.17 on Tuesday while NASDAQ dropped 1.26% to $12,560.25.
Earnings Per Share
As for profitability, BioNTech SE has a trailing twelve months EPS of $27.98.
PE Ratio
BioNTech SE has a trailing twelve months price to earnings ratio of 4.22. Meaning, the purchaser of the share is investing $4.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.49%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BioNTech SE’s stock is considered to be oversold (<=20).
Moving Average
BioNTech SE’s worth is under its 50-day moving average of $119.62 and way under its 200-day moving average of $140.81.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 114.8% and a negative 86.2%, respectively.
Volatility
BioNTech SE’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.45%, a negative 0.53%, and a positive 1.55%.
BioNTech SE’s highest amplitude of average volatility was 0.76% (last week), 1.58% (last month), and 1.55% (last quarter).
More news about BioNTech SE.
2. Moderna (MRNA) – 9.73%
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Moderna jumping 9.73% to $139.07 on Tuesday, after two sequential sessions in a row of gains. NASDAQ dropped 1.26% to $12,560.25, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Moderna has a trailing twelve months EPS of $11.86.
PE Ratio
Moderna has a trailing twelve months price to earnings ratio of 11.73. Meaning, the purchaser of the share is investing $11.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.62%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 176.7% and a negative 70.4%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 69.3%, now sitting on 15.06B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Moderna’s stock is considered to be oversold (<=20).
Volatility
Moderna’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.33%, a negative 0.51%, and a positive 2.06%.
Moderna’s highest amplitude of average volatility was 0.42% (last week), 1.68% (last month), and 2.06% (last quarter).
More news about Moderna.
3. Tupperware Brands Corporation (TUP) – 8.83%
Tupperware Brands Corporation operates as a consumer products company worldwide. The company manufactures, markets, and sells design-centric preparation, storage, and serving solutions for the kitchen and home, as well as a line of cookware, knives, microwave products, microfiber textiles, water-filtration related items, and an array of products for on-the-go consumers under the Tupperware brand name. It distributes its products to approximately 70 countries primarily through independent sales force members, including independent distributors, directors, managers, and dealers. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. Tupperware Brands Corporation was founded in 1946 and is headquartered in Orlando, Florida.
NYSE ended the session with Tupperware Brands Corporation jumping 8.83% to $0.92 on Tuesday while NYSE slid 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Tupperware Brands Corporation has a trailing twelve months EPS of $-0.71.
Yearly Top and Bottom Value
Tupperware Brands Corporation’s stock is valued at $0.92 at 17:32 EST, way below its 52-week high of $12.86 and way above its 52-week low of $0.66.
Sales Growth
Tupperware Brands Corporation’s sales growth is negative 31.7% for the current quarter and negative 15.3% for the next.
More news about Tupperware Brands Corporation.
4. Fastly (FSLY) – 7.6%
Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.
NYSE ended the session with Fastly rising 7.6% to $14.48 on Tuesday while NYSE slid 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Fastly has a trailing twelve months EPS of $-1.42.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Fastly’s stock is considered to be overbought (>=80).
More news about Fastly.
5. Xenetic Biosciences (XBIO) – 7.55%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences rising 7.55% to $2.99 on Tuesday while NASDAQ slid 1.26% to $12,560.25.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-3.86.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.9%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Xenetic Biosciences’s EBITDA is 6.09.
Revenue Growth
Year-on-year quarterly revenue growth grew by 46.4%, now sitting on 1.71M for the twelve trailing months.
Volume
Today’s last reported volume for Xenetic Biosciences is 59483 which is 197.43% above its average volume of 19999.
More news about Xenetic Biosciences.
6. Telephone and Data Systems (TDS) – 7.48%
Telephone and Data Systems, Inc., a telecommunications company, provides communications services in the United States. It operates through two segments: UScellular and TDS Telecom. The company offers wireless solutions to consumers and business and government customers, including a suite of connected Internet of things (IoT) solutions, and software applications for monitor and control, business automation/operations, communication, fleet and asset management, smart water solutions, private cellular networks and custom, and end-to-end IoT solutions; wireless priority services and quality priority and preemption options; smartphones and other handsets, tablets, wearables, mobile hotspots, routers, and IoT devices; and accessories, such as cases, screen protectors, chargers, and memory cards, as well as consumer electronics, including audio, home automation and networking products. It also provides replace and repair services; Trade-In program through which it buys customers' used equipment; internet connections and all-home WI-FI services; TDS TV+, an integrated cloud television platform that offers video content; local and long-distance telephone service, VoIP, and enhanced services; and broadband, IP-based services, and hosted voice and video collaboration services. The company sells its products through retail sales, direct and indirect sales, third-party retailers, and independent agents, as well as through ecommerce and telesales. Telephone and Data Systems, Inc. was incorporated in 1968 and is headquartered in Chicago, Illinois.
NYSE ended the session with Telephone and Data Systems jumping 7.48% to $7.47 on Tuesday while NYSE dropped 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Telephone and Data Systems has a trailing twelve months EPS of $-0.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.18%.
Sales Growth
Telephone and Data Systems’s sales growth is negative 4% for the present quarter and negative 3.1% for the next.
Volume
Today’s last reported volume for Telephone and Data Systems is 3055860 which is 40% above its average volume of 2182750.
More news about Telephone and Data Systems.
7. VerifyMe (VRME) – 6.52%
VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.
NASDAQ ended the session with VerifyMe jumping 6.52% to $1.47 on Tuesday, following the last session’s upward trend. NASDAQ dropped 1.26% to $12,560.25, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, VerifyMe has a trailing twelve months EPS of $-1.69.
Volatility
VerifyMe’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.14%, a negative 0.99%, and a positive 4.15%.
VerifyMe’s highest amplitude of average volatility was 3.50% (last week), 5.12% (last month), and 4.15% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VerifyMe’s stock is considered to be overbought (>=80).
More news about VerifyMe.
8. Palantir (PLTR) – 6.46%
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides Palantir Apollo, a software that enables customers to deploy their own software virtually in any environment. Palantir Technologies Inc. was incorporated in 2003 and is based in Denver, Colorado.
NYSE ended the session with Palantir jumping 6.46% to $12.60 on Tuesday, after two consecutive sessions in a row of gains. NYSE slid 0.96% to $15,172.27, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Palantir has a trailing twelve months EPS of $-0.12.
Sales Growth
Palantir’s sales growth is 12.4% for the current quarter and 17.7% for the next.
Volume
Today’s last reported volume for Palantir is 129117000 which is 202.57% above its average volume of 42672600.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Palantir’s stock is considered to be oversold (<=20).
More news about Palantir.
9. Novavax (NVAX) – 6.43%
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
NASDAQ ended the session with Novavax jumping 6.43% to $8.02 on Tuesday while NASDAQ dropped 1.26% to $12,560.25.
Earnings Per Share
As for profitability, Novavax has a trailing twelve months EPS of $-15.28.
Sales Growth
Novavax’s sales growth is 27.7% for the present quarter and negative 53.1% for the next.
Volume
Today’s last reported volume for Novavax is 4103900 which is 35.57% below its average volume of 6370470.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 79.8% and 81.9%, respectively.
Moving Average
Novavax’s worth is higher than its 50-day moving average of $7.53 and way under its 200-day moving average of $16.75.
More news about Novavax.
10. Tidewater (TDW) – 6.37%
Tidewater Inc., together with its subsidiaries, provides offshore support vessels and marine support services to the offshore energy industry through the operation of a fleet of marine service vessels worldwide. It provides services in support of offshore crude oil and natural gas exploration, field development, and production, as well as windfarm development and maintenance, including towing of and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workover, and production activities; offshore construction, and seismic and subsea support; geotechnical survey support for windfarm construction; and various specialized services, such as pipe and cable laying. The company operates anchor handling towing supply vessels, platform supply vessels, crew boats, utility vessels, and offshore tugs. The company serves oil and natural gas exploration, field development, and production companies; mid-sized and smaller independent exploration and production companies; foreign government-owned or government-controlled organizations, and other related companies; drilling contractors; and other companies, such as offshore construction, windfarm development, diving, and well stimulation companies. Tidewater Inc. was incorporated in 1956 and is headquartered in Houston, Texas.
NYSE ended the session with Tidewater rising 6.37% to $47.92 on Tuesday while NYSE dropped 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Tidewater has a trailing twelve months EPS of $0.01.
PE Ratio
Tidewater has a trailing twelve months price to earnings ratio of 4792. Meaning, the purchaser of the share is investing $4792 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.11%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tidewater’s EBITDA is 3.25.
More news about Tidewater.
Losers Today
1. Safeguard Scientifics New (SFE) – -9.77%
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
NYSE ended the session with Safeguard Scientifics New sliding 9.77% to $1.57 on Tuesday, after three sequential sessions in a row of losses. NYSE fell 0.96% to $15,172.27, after two consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Safeguard Scientifics New has a trailing twelve months EPS of $-0.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.46%.
Moving Average
Safeguard Scientifics New’s value is way below its 50-day moving average of $1.80 and way below its 200-day moving average of $3.04.
More news about Safeguard Scientifics New.
2. Canopy Growth (CGC) – -9.4%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth falling 9.4% to $1.06 on Tuesday while NASDAQ dropped 1.26% to $12,560.25.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112%.
Moving Average
Canopy Growth’s worth is way below its 50-day moving average of $2.11 and way under its 200-day moving average of $2.80.
Volatility
Canopy Growth’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.88%, a negative 1.05%, and a positive 2.72%.
Canopy Growth’s highest amplitude of average volatility was 2.88% (last week), 3.40% (last month), and 2.72% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canopy Growth’s stock is considered to be oversold (<=20).
More news about Canopy Growth.
3. Heico Corporation (HEI) – -7.95%
HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services. The company's Flight Support Group segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; renewable/reusable insulation systems; and specialty components. This segment also distributes hydraulic, pneumatic, structural, interconnect, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial aircraft, as well as for avionics and navigation systems, subcomponents, and other instruments utilized on military aircraft. Its Electronic Technologies Group segment provides electro-optical infrared simulation and test equipment; electro-optical laser products; electro-optical, microwave, and other power equipment; electromagnetic and radio frequency (RF) interference shielding and suppression filters; power conversion and interface products; interconnection devices; power electronics; and underwater locator beacons and emergency locator transmission beacons. This segment also offers traveling wave tube amplifiers and microwave power modules; memory products and specialty semiconductors; harsh environment connectivity products and custom molded cable assemblies; RF and microwave products; communications and electronic intercept receivers and tuners; self-sealing auxiliary fuel systems; active antenna systems and airborne antennas; nuclear radiation detectors; silicone products; power amplifiers; ceramic-to-metal feedthroughs and connectors; technical surveillance countermeasures equipment; RF receivers and sources; embedded computing solutions; test sockets and adapters; and radiation assurance services. The company was founded in 1957 and is headquartered in Hollywood, Florida.
NYSE ended the session with Heico Corporation falling 7.95% to $164.72 on Tuesday while NYSE dropped 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Heico Corporation has a trailing twelve months EPS of $2.59.
PE Ratio
Heico Corporation has a trailing twelve months price to earnings ratio of 63.6. Meaning, the purchaser of the share is investing $63.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.05%.
Previous days news about Heico Corporation
- Heico corporation (hei) beats Q2 earnings and revenue estimates. According to Zacks on Monday, 22 May, "While Heico Corporation has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Here's what key metrics tell us about heico corporation (hei) Q2 earnings. According to Zacks on Monday, 22 May, "Here is how Heico Corporation performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Heico Corporation.
4. 10x Genomics (TXG) – -7.48%
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
NASDAQ ended the session with 10x Genomics falling 7.48% to $52.83 on Tuesday, after four consecutive sessions in a row of gains. NASDAQ fell 1.26% to $12,560.25, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, 10x Genomics has a trailing twelve months EPS of $-1.48.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.67%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 29.8% and 13.5%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.3%, now sitting on 536.2M for the twelve trailing months.
Volatility
10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was 2.29%, 0.29%, and 2.60%.
10x Genomics’s highest amplitude of average volatility was 2.29% (last week), 1.97% (last month), and 2.60% (last quarter).
More news about 10x Genomics.
5. Zoom (ZM) – -7.27%
Zoom Video Communications, Inc. provides unified communications platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. The company offers Zoom Meetings that offers HD video, voice, chat, and content sharing through mobile devices, desktops, laptops, telephones, and conference room systems; Zoom Phone, an enterprise cloud phone system; and Zoom Chat enables users to share messages, images, audio files, and content in desktop, laptop, tablet, and mobile devices. It also provides Zoom Rooms, a software-based conference room system; Zoom Hardware-as-a-Service allows users to access video communication technology from third party equipment; Zoom Conference Room Connector, a gateway for SIP/H.323 endpoints to join Zoom meetings; Zoom Events, which enables users to manage and host internal and external virtual events; OnZoom, a prosumer-focused virtual event platform and marketplace for Zoom users to create, host, and monetize online events; and Zoom Webinars to provide video presentations to large audiences from many devices. In addition, the company offers Zoom Developer Platform that enables developers, platform integrators, service providers, and customers to build apps and integrations using Zoom's video-based communications solutions, as well as integrate Zoom's technology into their products and services; Zoom App Marketplace, which helps developers to publish their apps, as well as third-party integrations of Zoom; and Zoom Contact Center, an omnichannel contact center solution. It serves individuals; and education, entertainment/media, enterprise infrastructure, finance, government, healthcare, manufacturing, non-profit/not for profit and social impact, retail/consumer products, and software/Internet industries. The company was formerly known as Zoom Communications, Inc. and changed its name to Zoom Video Communications, Inc. in May 2012. The company was incorporated in 2011 and is headquartered in San Jose, California.
NASDAQ ended the session with Zoom dropping 7.27% to $66.22 on Tuesday, following the last session’s upward trend. NASDAQ fell 1.26% to $12,560.25, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
Zoom (zm) Q1 earnings beat, customer growth drives revenuesZoom Video Communications, Inc. price-consensus-eps-surprise-chart | Zoom Video Communications, Inc. Quote, For fiscal 2024, Zoom expects revenues in the range of $4.465 billion to $4.485 billion.
Zoom video communications (zm) stock earnings: enterprise sales rise 13%, while online segment declinesIf Zoom stock fails to break above that recent high, then shares will quickly sell off back to support at least at the 21-day moving average, which is at $64.36. , After advancing 1.5% on Monday evening, Zoom stock is down 0.2% in Tuesday’s premarket.
Earnings Per Share
As for profitability, Zoom has a trailing twelve months EPS of $0.36.
PE Ratio
Zoom has a trailing twelve months price to earnings ratio of 183.94. Meaning, the purchaser of the share is investing $183.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.73%.
Yearly Top and Bottom Value
Zoom’s stock is valued at $66.22 at 17:32 EST, way under its 52-week high of $124.05 and higher than its 52-week low of $60.45.
Sales Growth
Zoom’s sales growth is 0.9% for the ongoing quarter and 0.8% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Zoom’s EBITDA is -160.89.
More news about Zoom.
6. Riot Blockchain (RIOT) – -7.04%
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain sliding 7.04% to $11.34 on Tuesday while NASDAQ dropped 1.26% to $12,560.25.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-4.29.
More news about Riot Blockchain.
7. AutoZone (AZO) – -7.01%
AutoZone, Inc. retails and distributes automotive replacement parts and accessories. The company offers various products for cars, sport utility vehicles, vans, and light trucks, including new and remanufactured automotive hard parts, maintenance items, accessories, and non-automotive products. Its products include A/C compressors, batteries and accessories, bearings, belts and hoses, calipers, chassis, clutches, CV axles, engines, fuel pumps, fuses, ignition and lighting products, mufflers, radiators, starters and alternators, thermostats, and water pumps, as well as tire repairs. In addition, the company offers maintenance products, such as antifreeze and windshield washer fluids; brake drums, rotors, shoes, and pads; brake and power steering fluids, and oil and fuel additives; oil and transmission fluids; oil, cabin, air, fuel, and transmission filters; oxygen sensors; paints and accessories; refrigerants and accessories; shock absorbers and struts; spark plugs and wires; and windshield wipers. Further, it provides air fresheners, cell phone accessories, drinks and snacks, floor mats and seat covers, interior and exterior accessories, mirrors, performance products, protectants and cleaners, sealants and adhesives, steering wheel covers, stereos and radios, tools, and wash and wax products, as well as towing services. Additionally, the company provides a sales program that offers commercial credit and delivery of parts and other products; sells automotive diagnostic and repair software under the ALLDATA brand through alldata.com and alldatadiy.com; and automotive hard parts, maintenance items, accessories, and non-automotive products through autozone.com. It has stores in the United States, Mexico, and Brazil. The company was founded in 1979 and is based in Memphis, Tennessee.
NYSE ended the session with AutoZone dropping 7.01% to $2,436.14 on Tuesday, following the last session’s downward trend. NYSE slid 0.96% to $15,172.27, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
: autozone earnings hit by weaker-than-expected sales in March, stock slides 3% premarketMemphis, Tenn.-based AutoZone had net income of $648.7 million, or $34.12 a share, for the quarter to May 6, up from $592.6 million, or $29.03 a share, in the year-earlier period.
Earnings Per Share
As for profitability, AutoZone has a trailing twelve months EPS of $121.52.
PE Ratio
AutoZone has a trailing twelve months price to earnings ratio of 20.05. Meaning, the purchaser of the share is investing $20.05 for every dollar of annual earnings.
Volume
Today’s last reported volume for AutoZone is 317383 which is 122.53% above its average volume of 142622.
More news about AutoZone.
8. Aurora Cannabis (ACB) – -6.72%
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
NYSE ended the session with Aurora Cannabis falling 6.72% to $0.62 on Tuesday while NYSE fell 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-6.21.
Sales Growth
Aurora Cannabis’s sales growth is 27.5% for the current quarter and 26.6% for the next.
More news about Aurora Cannabis.
9. Align Technology (ALGN) – -6.47%
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
NASDAQ ended the session with Align Technology dropping 6.47% to $281.38 on Tuesday, following the last session’s upward trend. NASDAQ dropped 1.26% to $12,560.25, following the last session’s upward trend on what was an all-around negative trend exchanging session today.
Earnings Per Share
As for profitability, Align Technology has a trailing twelve months EPS of $4.04.
PE Ratio
Align Technology has a trailing twelve months price to earnings ratio of 69.65. Meaning, the purchaser of the share is investing $69.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.82%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Align Technology’s stock is considered to be oversold (<=20).
More news about Align Technology.
10. Las Vegas Sands Corp (LVS) – -6.27%
Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Macao and Singapore. It owns and operates The Venetian Macao Resort Hotel, the Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, Cotai Strip, and the Sands Macao in Macao, the People's Republic of China; and Marina Bay Sands in Singapore. The company's integrated resorts feature accommodations, gaming, entertainment and retail malls, convention and exhibition facilities, celebrity chef restaurants, and other amenities. Las Vegas Sands Corp. was founded in 1988 and is based in Las Vegas, Nevada.
NYSE ended the session with Las Vegas Sands Corp dropping 6.27% to $55.76 on Tuesday while NYSE fell 0.96% to $15,172.27.
Earnings Per Share
As for profitability, Las Vegas Sands Corp has a trailing twelve months EPS of $-0.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.58%.
More news about Las Vegas Sands Corp.
Stay up to date with our winners and losers daily report
